ABERA: 7% organic growth and stable margins in Q1 2026, with strong energy and infrastructure demand

About this update from Abera Bioscience Ab

Q1 2026 saw 7% organic revenue growth and stable profitability, with strong performance in Renewable Energy and Infrastructure. The order book remains robust at NOK 7.6bn, while integration of recent acquisitions and major project wins support future growth.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Abera Bioscience Ab